122 related articles for article (PubMed ID: 8587441)
1. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart.
Wang QD; Li XS; Pernow J
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S445-7. PubMed ID: 8587441
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Wang QD; Li XS; Lundberg JM; Pernow J
Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat.
Li XS; Wang QD; Pernow J
Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.
Gonon AT; Bulhak A; Bröijersén A; Pernow J
Br J Pharmacol; 2005 Mar; 144(6):860-6. PubMed ID: 15685207
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin.
Massoudy P; Zahler S; Kupatt C; Reder E; Becker BF; Gerlach E
J Mol Cell Cardiol; 1997 Feb; 29(2):535-44. PubMed ID: 9140813
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
[TBL] [Abstract][Full Text] [Related]
7. Effects of endothelin-1 and L-arginine after cold ischemia in lamb hearts.
Hiramatsu T; Forbess JM; Miura T; Roth SJ; Cioffi MA; Mayer JE
Ann Thorac Surg; 1996 Jan; 61(1):36-40; discussion 40-1. PubMed ID: 8561606
[TBL] [Abstract][Full Text] [Related]
8. Combined blockade of endothelin-1 and thromboxane A(2) receptors against postischaemic contractile dysfunction in rat hearts.
Hornstein PS; Zaugg CE; Zhu P; Allegrini PR; Buser PT
Br J Pharmacol; 2001 Jan; 132(1):234-40. PubMed ID: 11156582
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart.
Dagassan PH; Breu V; Clozel M; Clozel JP
J Cardiovasc Pharmacol; 1994 Dec; 24(6):867-74. PubMed ID: 7898067
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.
de Groot MC; Illing B; Horn M; Urban B; Haase A; Schnackerz K; Neubauer S
J Mol Cell Cardiol; 1998 Dec; 30(12):2657-68. PubMed ID: 9990537
[TBL] [Abstract][Full Text] [Related]
12. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
Xia Z; Kuo KH; McNeill JH; Ansley DM
Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840
[TBL] [Abstract][Full Text] [Related]
13. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans.
Böhm F; Settergren M; Gonon AT; Pernow J
Clin Sci (Lond); 2005 Apr; 108(4):357-63. PubMed ID: 15610070
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic effect of endothelin-A receptor antagonist on acute ischemic arrhythmia in isolated rat heart.
Xu H; Lin L; Yuan WJ
Acta Pharmacol Sin; 2003 Jan; 24(1):37-44. PubMed ID: 12511227
[TBL] [Abstract][Full Text] [Related]
15. Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1995 Sep; 116(2):1745-50. PubMed ID: 8528554
[TBL] [Abstract][Full Text] [Related]
16. Control of the cardiac consequences of myocardial ischemia and reperfusion by L-propionylcarnitine: age-response and dose-response studies in the rat heart.
Riva E; Leopaldi D
Pediatr Res; 1993 Oct; 34(4):465-70. PubMed ID: 8255679
[TBL] [Abstract][Full Text] [Related]
17. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
[TBL] [Abstract][Full Text] [Related]
18. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts.
Maczewski M; Beresewicz A
J Mol Cell Cardiol; 2000 Feb; 32(2):297-310. PubMed ID: 10722805
[TBL] [Abstract][Full Text] [Related]
19. Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats.
Besse S; Tanguy S; Riou B; Boucher F; Bulteau AL; Le Page C; Swynghedauw B; de Leiris J
Eur J Pharmacol; 2001 Dec; 432(2-3):167-75. PubMed ID: 11740953
[TBL] [Abstract][Full Text] [Related]
20. Role of endogenous endothelin on coronary reflow after cardioplegic arrest.
Goodwin AT; Smolenski RT; Gray CC; Jayakumar J; Amrani M; Yacoub MH
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1167-73. PubMed ID: 11726892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
